[1]
“Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slove-nian real-world data”, Radiol Oncol, vol. 60, no. 2, pp. 288–293, Jul. 2026, Accessed: Oct. 24, 2026. Available: https://radioloncol.com/index.php/ro/article/view/4731